The preoperative management of meibomian gland dysfunction prior to corneal refractive surgery

Jenna Tauber, Thomas Kennedy, Viral Juthani

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Purpose of reviewTo describe the significance of meibomian gland dysfunction (MGD) in corneal refractive surgery and to describe available approaches to preoperative evaluation and treatment based on current research.Recent findingsThere are several methods available for the evaluation and treatment of MGD. These are relevant for refractive surgeons to understand, as the presence of MGD preoperatively plays a role in the severity of MGD after corneal refractive surgery. Refractive surgery itself can exacerbate MGD. Treatment of MGD prior to surgery may have a meaningful impact on postoperative MGD.SummarySurgeons should include meibomian gland assessment in the preoperative refractive evaluation and should treat MGD proactively prior to performing refractive surgery. Relevant information in this field is growing; additional prospectively designed studies are needed to further enhance our understanding.

Original languageEnglish (US)
Pages (from-to)251-257
Number of pages7
JournalCurrent opinion in ophthalmology
Volume33
Issue number4
DOIs
StatePublished - Jul 1 2022

Keywords

  • corneal refractive disease
  • meibomian gland dysfunction

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'The preoperative management of meibomian gland dysfunction prior to corneal refractive surgery'. Together they form a unique fingerprint.

Cite this